Spotlight Innovation reveals debt restructuring plan

Spotlight Innovation, a pharmaceutical holding company that acquires rights to proprietary technologies, is restructuring debt through a conversion of promissory notes.

Advertisement

The company said the holders of a series of convertible promissory notes issued between December 2015 and March 2016, totaling $850,000, have agreed to convert the promissory notes into shares of common stock.

“This conversion is a positive step toward simplifying our balance sheet,” Cristopher Grunewald, Spotlight Innovation’s president and CEO, said in a statement. “Debt restructuring allows us to accelerate development of our product candidates, creating value for both current and future shareholders. Moving forward, we will continue to look for debt restructuring opportunities that further our development goals.”

 

More articles on finance:

KentuckyOne Health lays off 3 top executives
55 employers with the best healthy lifestyle initiatives
Board of Allina-run hospital votes to dissolve

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.